Ironwood Pharmaceuticals (IRWD) EV to FCF (2010 - 2026)

Ironwood Pharmaceuticals has disclosed EV to FCF across 17 years of filings, most recently posting 10.58 for Q2 2026.

• In Q2 2026, EV to FCF rose 761.53% year-over-year to 10.58; the TTM figure through Jun 2026 stood at 3.32 (up 312.72% YoY), while the FY2025 annual figure was 2.63, down 56.21% from the prior year.
• EV to FCF came in at 10.58 for Q2 2026 at Ironwood Pharmaceuticals, down from 69.78 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 69.78 in Q1 2026 to a low of 1.6 in Q2 2025.
• Average EV to FCF over 5 years is 25.69, with a median of 20.86 recorded in 2022.
• Year-over-year, EV to FCF tumbled 105.71% in 2025 and soared 974.48% in 2026.
• Over 5 years, EV to FCF stood at 15.79 in 2022, then jumped by 201.57% to 47.62 in 2023, then retreated by 14.27% to 40.83 in 2024, then tumbled by 89.03% to 4.48 in 2025, then surged by 136.19% to 10.58 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 10.58 in Q2 2026, 69.78 in Q1 2026, and 4.48 in Q4 2025.